﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Advanced Pharmaceutical Bulletin</JournalTitle>
      <Issn>2228-5881</Issn>
      <Volume>9</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2019</Year>
        <Month>02</Month>
        <DAY>21</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Cancer Cells Treated by Clusters of Copper Oxide Doped Calcium Silicate</ArticleTitle>
    <FirstPage>102</FirstPage>
    <LastPage>109</LastPage>
    <ELocationID EIdType="doi">10.15171/apb.2019.013</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mostafa</FirstName>
        <LastName>Mabrouk</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-3330-6762</Identifier>
      </Author>
      <Author>
        <FirstName>Sayed Hamed</FirstName>
        <LastName>Kenawy</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-0974-4837</Identifier>
      </Author>
      <Author>
        <FirstName>Gehan El Tabie</FirstName>
        <LastName>El-Bassyouni</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-8438-0570</Identifier>
      </Author>
      <Author>
        <FirstName>Ahmed Abd El-Fattah</FirstName>
        <LastName>Ibrahim Soliman</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-5046-8088</Identifier>
      </Author>
      <Author>
        <FirstName>Esmat Mahmoud</FirstName>
        <LastName>Aly Hamzawy</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-0984-9911</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.15171/apb.2019.013</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2018</Year>
        <Month>05</Month>
        <Day>13</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>11</Month>
        <Day>12</Day>
      </PubDate>
    </History>
    <Abstract>Purpose: Different compositions of copper oxide (CuO)-doped calcium silicate clusters wereused to treat the cancer cells.Methods: The influence of CuO content on the morphology, drug delivering ability,physicochemical properties and cytotoxicity was investigated.Results: The microcrystalline structure revealed the decrement of the size from (20-36 nm) to(5-7 nm) depending on the copper content percentages. Drug delivering ability of doxycyclinehyclate (Dox) was down regulated from 58% to 28%in the presence of the CuO. The inclusionof CuO and Dox didn’t show any remarkable changes on the physicochemical properties of theCuO-doped calcium silicate nanoparticles.Conclusion: The CuO-doped calcium silicate sample (5 weight %) exhibited great cytotoxicityagainst the tested cell lines compared to the CuO-free sample. CuO-doped materials displayedsignificant anticancer effect; this sheds light on its implication in the treatment of cancer. </Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Copper oxide</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Cytotoxicity</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Doxycycline hyclate</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Chemical precipitation</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>